Olga Mostovaya

Mrs. Olga Mostovaya


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
OMOlga Mostovaya
Olga Mostovaya
Pavel PadnyaPavel Padnya
Pavel Padnya
ISIgor Shiabiev
Igor Shiabiev
TMTimur A. Mukhametzyanov
Timur A. Mukhametzyanov
Ivan StoikovIvan Stoikov
Ivan Stoikov
A convenient method for the synthesis of the first generation PAMAM dendrimers based on the thiacalix[4]arene has been developed for the first time. Three new PAMAM-calix-dendrimers with the macrocyclic core in cone, partial cone, and 1,3-alternate conformations were obtained with high yields. The interaction of the obtained compounds with salmon sperm DNA resulted in the formation of the associates of the size up to 200 nm, as shown by the UV-Vis spectroscopy, DLS, and TEM. It was demonstrated by the CD method that the structure of the DNA did not undergo significant changes upon binding. The PAMAM-calix-dendrimer based on the macrocycle in cone conformation stabilized DNA and prevented its degradation.

Verified
Journal Article
Open access
PDF file
AKAlena Khadieva
Alena Khadieva
OMOlga Mostovaya
Olga Mostovaya
Pavel PadnyaPavel Padnya
Pavel Padnya
VKValery Kalinin
Valery Kalinin
Denis GrishaevDenis Grishaev
Denis Grishaev
Ivan StoikovIvan Stoikov
Ivan Stoikov
The synthesis of new phenothiazine derivatives, analogs of Methylene Blue, is of particular interest in the design of new drugs, as well as in the development of a new generation of agents for photodynamic therapy. In this study, two new derivatives of phenothiazine, i.e., 3,7-bis(4-aminophenylamino)phenothiazin-5-ium chloride dihydrochloride (PTZ1) and 3,7-bis(4-sulfophenylamino)phenothiazin-5-ium chloride (PTZ2), are synthesized for the first time and characterized by NMR, IR spectroscopy, HRMS and elemental analysis. The interaction of the obtained compounds PTZ1 and PTZ2 with salmon sperm DNA is investigated. It is shown by UV-Vis spectroscopy and DFT calculations that substituents in arylamine fragments play a crucial role in dimer formation and interaction with DNA. In the case of PTZ1, two amine groups promote H-aggregate formation and DNA interactions through groove binding and intercalation. In the case of PTZ2, sulfanilic acid fragments prevent any dimer formation and DNA binding due to electrostatic repulsion. DNA interaction mechanisms are studied and confirmed by UV-vis and fluorescence spectroscopy in comparison with Methylene Blue. The obtained results open significant opportunities for the development of new drugs and photodynamic agents.

8 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
OMOlga Mostovaya
Olga Mostovaya
ISIgor Shiabiev
Igor Shiabiev
DPDmitry Pysin
Dmitry Pysin
ASAlesia Stanavaya
Alesia Stanavaya
VAViktar Abashkin
Viktar Abashkin
Ivan StoikovIvan Stoikov
Ivan Stoikov
A convenient method for the synthesis of the second generation of PAMAM dendrimers based on a p-tert-butylthiacalix[4]arene core in cone, partial cone and 1,3-alternate conformations was developed. Unusual fluorescence of the obtained PAMAM-calix-dendrimers has been found and explained. The binding ability of the synthesized dendrimers toward catecholamines (dopamine, L-adrenaline and L-noradrenaline) was shown by UV-Vis, fluorescence, 1D and 2D NMR spectroscopy and the binding constants (logKa 3.85–4.74) calculated. As was shown, the PAMAM-calix-dendrimers bind catecholamines by the internal cavities. All the studied hormones were most efficiently bound by the dendrimers bearing a macrocyclic core in 1,3-alternate conformation. The size of the formed supramolecular systems of dendrimer/catecholamine was established by the DLS method. A decrease in hemolytic activity of the PAMAM-calix-dendrimers with an increase in the generation number of a dendrimer was shown for the dendrimers with a core in 1,3-alternate conformation. The prospects for the use of the synthesized dendrimers with the macrocyclic core as drug delivery agents were discussed.

9 May 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Dmitriy ShurpikDmitriy Shurpik
Dmitriy Shurpik
YAYulia I. Aleksandrova
Yulia I. Aleksandrova
OMOlga Mostovaya
Olga Mostovaya
VNViktoriya A. Nazmutdinova
Viktoriya A. Nazmutdinova
RTRegina E. Tazieva
Regina E. Tazieva
Ivan StoikovIvan Stoikov
Ivan Stoikov
Polymer self-healing films containing fragments of pillar[5]arene were obtained for the first time using thiol/disulfide redox cross-linking. These films were characterized by thermogravimetric analysis and differential scanning calorimetry, FTIR spectroscopy, and electron microscopy. The films demonstrated the ability to self-heal through the action of atmospheric oxygen. Using UV–vis, 2D 1H-1H NOESY, and DOSY NMR spectroscopy, the pillar[5]arene was shown to form complexes with the antimicrobial drug moxifloxacin in a 2:1 composition (logK11 = 2.14 and logK12 = 6.20). Films containing moxifloxacin effectively reduced Staphylococcus aureus and Klebsiella pneumoniae biofilms formation on adhesive surfaces.

8 April 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Dmitriy ShurpikDmitriy Shurpik
Dmitriy Shurpik
LMLyaysan Makhmutova
Lyaysan Makhmutova
KUKonstantin Usachev
Konstantin Usachev
DIDaut Islamov
Daut Islamov
OMOlga Mostovaya
Olga Mostovaya
Ivan StoikovIvan Stoikov
Ivan Stoikov
In this work, we have proposed a novel universal stimulus-sensitive nanosized polymer system based on decasubstituted macrocyclic structures—pillar[5]arenes and tetrazole-containing polymers. Decasubstituted pillar[5]arenes containing a large, good leaving tosylate, and phthalimide groups were first synthesized and characterized. Pillar[5]arenes containing primary and tertiary amino groups, capable of interacting with tetrazole-containing polymers, were obtained with high yield by removing the tosylate and phthalimide protection. According to the fluorescence spectroscopy data, a dramatic fluorescence enhancement in the pillar[5]arene/fluorescein/polymer system was observed with decreasing pH from neutral (pH = 7) to acidic (pH = 5). This indicates the destruction of associates and the release of the dye at a pH close to 5. The presented results open a broad range of opportunities for the development of new universal stimulus-sensitive drug delivery systems containing macrocycles and nontoxic tetrazole-based polymers.

Verified
Journal Article
Open access
PDF file
ANAnastasia Nazarova
Anastasia Nazarova
ISIgor Shiabiev
Igor Shiabiev
KSKsenia Shibaeva
Ksenia Shibaeva
OMOlga Mostovaya
Olga Mostovaya
TMTimur A. Mukhametzyanov
Timur A. Mukhametzyanov
Ivan StoikovIvan Stoikov
Ivan Stoikov
Amyloid fibroproliferation leads to organ damage and is associated with a number of neurodegenerative diseases affecting populations worldwide. There are several ways to protect against fibril formation, including inhibition. A variety of organic compounds based on molecular recognition of amino acids within the protein have been proposed for the design of such inhibitors. However, the role of macrocyclic compounds, i.e., thiacalix[4]arenes, in inhibiting fibrillation is still almost unknown. In the present work, the use of water-soluble thiacalix[4]arene derivatives for the inhibition of hen egg-white lysozyme (HEWL) amyloid fibrillation is proposed for the first time. The binding of HEWL by the synthesized thiacalix[4]arenes (logKa = 5.05–5.13, 1:1 stoichiometry) leads to the formation of stable supramolecular systems capable of stabilizing the protein structure and protecting against fibrillation by 29–45%. The macrocycle conformation has little effect on protein binding strength, and the native HEWL secondary structure does not change via interaction. The synthesized compounds are non-toxic to the A549 cell line in the range of 0.5–250 µg/mL. The results obtained may be useful for further investigation of the anti-amyloidogenic role of thiacalix[4]arenes, and also open up future prospects for the creation of new ways to prevent neurodegenerative diseases.